Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-06-01 Purchase | 2021-06-03 5:31 pm | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | VEDANTA PARTNERS LLC Vedanta Associates-R LP VEDANTA ASSOCIATES L.P. BETA OPERATORS FUND L.P. SAXENA PARAG 10% Owner | 1,330,000 | $3.75 | $4,987,500 | 2,699,876 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-10 Option Award | 2024-12-12 4:35 pm | N/A 2034-12-09 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | SAXENA PARAG Director 10% Owner | 8,200 | $0 | 8,200 (Direct) | View |
| 2023-11-20 Other | 2023-11-22 6:28 pm | N/A N/A | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | SAXENA PARAG VEDANTA PARTNERS LLC VEDANTA ASSOCIATES L.P. Director 10% Owner | 1,170,732 | $0 | 1,170,732 (Indirect) | View |
| 2023-11-13 Option Award | 2023-11-14 4:18 pm | N/A 2033-11-12 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | SAXENA PARAG Director 10% Owner | 8,200 | $0 | 8,200 (Direct) | View |
| 2022-11-10 Option Award | 2022-11-14 10:34 am | N/A 2032-11-09 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | SAXENA PARAG Director 10% Owner | 3,900 | $0 | 3,900 (Direct) | View |
| 2021-12-08 Option Award | 2021-12-10 4:49 pm | N/A 2031-12-07 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | SAXENA PARAG Director 10% Owner | 5,300 | $0 | 5,300 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-16 6:04 pm | N/A 2031-06-14 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | SAXENA PARAG Director 10% Owner | 4,000 | $0 | 4,000 (Direct) | View |
| 2020-12-15 Other | 2020-12-28 8:02 pm | 2020-12-14 2025-12-14 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Tenzing LLC SAXENA PARAG Nayar Rahul Director 10% Owner | 540,500 | $0 | 0 (Direct) | View |
| 2020-12-14 Option Award | 2020-12-28 8:00 pm | 2020-12-14 2025-12-14 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Tenzing LLC SAXENA PARAG Nayar Rahul Director 10% Owner | 197,500 | $0 | 3,005,250 (Direct) | View |
| 2020-12-14 Other | 2020-12-28 8:00 pm | 2020-12-14 2025-12-14 | REVIVA PHARMACEUTICALS HOLDINGS INC. | RVPH | Tenzing LLC SAXENA PARAG Nayar Rahul Director 10% Owner | 343,000 | $0 | 3,005,250 (Direct) | View |
| 2020-11-24 Other | 2020-11-27 4:06 pm | N/A N/A | Eucrates Biomedical Acquisition Corp. | EUCR | SAXENA PARAG Chief Executive Officer 10% Owner | 255,094 | $0 | 2,875,000 (Indirect) | View |
Ownership | 2020-10-23 1:24 pm | N/A N/A | Eucrates Biomedical Acquisition Corp. | EUCR | SAXENA PARAG Chief Executive Officer 10% Owner | 0 | $0 | 2,875,000 (Indirect) | View |